2024-11-10 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

This report provides a comprehensive analysis of UnitedHealth Group Inc. (UNH) stock, covering its performance, valuation, recent news, and analyst sentiment. 

### 1. Performance Analysis

**1.1.  Outperformance vs. S&P 500:**

* **UNH** has significantly outperformed the S&P 500 (VOO) with a **cumulative return of 312.12%** compared to the S&P 500's **141.71%**. 
* **This translates to a relative outperformance of 170.41%** which represents a **69.11% percentile** based on historical data.

**1.2. Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|------|
| 2015-2017 | 118.8% | 12.4% | 88.6% | 0.9 |
| 2016-2018 | 113.9% | 18.6% | 89.2% | 0.9 |
| 2017-2019 | 82.1% | 23.3% | 39.0% | 0.9 |
| 2018-2020 | 58.6% | 36.0% | 19.5% | 1.1 |
| 2019-2021 | 106.2% | 36.0% | 16.4% | 1.0 |
| 2020-2022 | 81.3% | 36.0% | 63.5% | 0.9 |
| 2021-2023 | 50.6% | 18.3% | 21.8% | 0.5 |
| 2022-2024 | 20.5% | 20.0% | -4.1% | 0.5 |

* **UNH consistently exhibits positive Alpha, suggesting it has outperformed the market.** 
* **Beta is generally around 0.9, implying lower volatility compared to the S&P 500.**

**1.3. Recent Price Movements:**

* **Last-market: 616.11**
* **Closing Price: 605.45**
* **5-Day Moving Average: 578.9**
* **20-Day Moving Average: 572.37**
* **60-Day Moving Average: 581.51**

* **The stock is trading above its 5, 20, and 60-day moving averages, suggesting positive momentum.**
* **The last market price of 616.11 indicates a recent surge in price, potentially a sign of strong buying pressure.**

### 2. Technical Indicators:

* **RSI (Relative Strength Index): 71.6** - Indicates the stock is in overbought territory.
* **PPO (Percentage Price Oscillator): 0.69** - Suggests bullish momentum but also potentially approaching an overbought condition.
* **Delta_Previous_Relative_Divergence (20-day): -1.38** - Shows a short-term downward trend in the stock's relative strength.

**Overall Technical Interpretation:**

* The stock is currently in overbought territory based on the RSI and PPO indicators, suggesting a potential correction in the short term. 
* The recent price surge (616.11) could be a short-term overshoot due to the overbought condition. 
* The short-term downward trend in relative divergence further reinforces the possibility of a correction.

### 3. Expected Return:

* **Expected Return (2 years): 53.23%** - Represents the potential for UNH to outperform the S&P 500 by a significant margin over a longer time frame.

**Important Note:** Expected returns are estimates and not guarantees. Market conditions and company performance can impact actual returns.

### 4. Recent Earnings and Forecasts:

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2024-11-04 | 6.31 | 92.36 B$ |

* **Recent earnings show a positive trend, with revenue consistently exceeding $90 billion.**
* **The most recent earnings (2024-11-04) surpassed analysts' expectations, further confirming positive performance.**

### 5. Financial Analysis:

**5.1. Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $99.18B | 21.56% |
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |

* **Strong Revenue Growth:**  UNH consistently generates significant revenue, demonstrating a strong market position in the healthcare industry.
* **High Profit Margin:**  UNH maintains a consistently high profit margin, indicating efficient operations and strong pricing power.

**5.2. Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $94.53B | 6.41% |
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |

* **Robust Equity Base:**  A healthy equity base suggests financial strength and stability.
* **Variable ROE:**  The ROE fluctuates, suggesting potential variations in profitability based on factors such as market competition and regulatory changes.

**Overall Financial Interpretation:**

* UNH demonstrates strong financial performance with consistent revenue growth, high profit margins, and a healthy equity base. 
* The fluctuating ROE highlights potential challenges and opportunities in the healthcare landscape.

### 6. News and Recent Issues:

* **Recent Earnings Release:** Analyze recent earnings news reports from sources like Shacknews for key takeaways and analyst reactions.
* **Analyst Opinions and Performance Highlights:** Refer to financial platforms like FINBOLD for recent analyst ratings, price targets, and performance highlights.

### 7. Conclusion:

UnitedHealth Group Inc. (UNH) continues to be a strong performer in the healthcare sector. It boasts a robust financial profile, significant outperformance compared to the market, and positive analyst sentiment. Despite its recent overbought condition, UNH's long-term prospects remain positive, driven by its strong financial foundation, market leadership, and ongoing growth potential. 

**For investors with a long-term horizon, UNH remains a compelling investment opportunity.** However, it's essential to monitor the stock's technical indicators for potential short-term corrections due to the current overbought condition. 
